Flexion Therapeutics on Friday earned Food and Drug Administration approval for Zilretta, an extended-release treatment for osteoarthritis knee pain. Here are three things to know. 1. Zilretta is ...
The FDA approved Flexion Therapeutics’ Zilretta, an intra-articular therapy for osteoarthritis knee pain. 1. Flexion is marketing the drug as the first and only extended-release intra-articular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback